Azịza ngwa ngwa
A main peak passes HPLC area-percent release while a closely related species hides inside it. That failure mode is the reason Q-2DMS in peptide characterizatio…
Kedu ihe kpatara otu akụkụ LC-MS ji ada na adịghị ọcha peptide nwere njikọ chiri anya?
Omenala Peptides N'ogbe Peptides ozugbo Usoro ọnwụ atọ na-arụ ọrụ n'usoro, na naanị nke mbụ ka a na-ahụ anya na chromatogram. Chromatographic ngalaba-elution na-etinye ụdị abụọ n'ime otu windo njide; nzacha nke dabere na data wee họrọ otu n'ime ha; n'okpuru sampling na-adaba ụdị dị ala nke na-adịghị erute oke ike. Ihe na-esi na ya pụta bụ chimeric spectrum, nke enweghị ike ikenye ion iberibe n'ime otu precursor.
A na-atụle oke ihe ga-esi na ya pụta. Na-arụ ọrụ na-akọwa chimeric MS/MS spectra na akụkọ nweta data dabere na chimeras nwere ike ịnọchite anya. 30 ka 50% nke mkpokọta MS/MS spectra anakọtara, na nke ahụ ọbụna na warara 2 m/z windo iche, 39% ụdịdị dị iche iche sitere na mgbari HeLa tryptic bụ chimeric (akwụkwọ usoro spectra nke chimeric na-ehota Houel et al. 2010 na Dorfer et al. 2018). Otu akwụkwọ ahụ kwuru na chimerism na-eweda akara nchọta site na MASCOT na SEQUEST ma na-ebute mkpakọ ruru na isobaric-tag quantification..
Ọnụ ọgụgụ na-enweghị atụ sitere na otu 2011 Akwụkwọ akụkọ nke Proteome Research ọmụmụ nke nnweta DDA: Ọnụego nyocha nke MS/MS 25 kwa nkeji ọ ga-adị mkpa iji gbado atụmatụ peptide niile achọpụtara, idobe n'okpuru 17 kwa nkeji maka peptides bara ụba nke ọma, na ọtụtụ atụmatụ chọrọ oge ịgba ọgwụ MS/MS karịa 250 ms (Michalski, Cox na Mann, 2011). Ndị ode akwụkwọ na-achọpụta mwepu ion precursor, ọ bụghị iṅomi ọsọ, dị ka njedebe kasịnụ.
Ihe bara uru "ya mere gịnị" bụ na ọdịda ahụ gbachiri nkịtị. Otu usoro nwere ike ịgafe nnwale ntọhapụ na pasenti mpaghara ebe ụdị na-emekọ ihe ọnụ na-enye aka irighiri ihe na-agbakọ n'ime ọnụ ọgụgụ kachasị elu., na ọ dịghị ihe na chromatogram flags ya. Nke ahụ bụ oghere a kapịrị ọnụ ka emebere usoro nyocha peptide mass spectrometry akụkụ abụọ ka emebere iji mechie., n'ihi na ọ na-ewepụ nzọụkwụ mbụ-nhọpụta kama ịkwalite ya.
Gịnị bụ Q-2DMS na otú o si dị iche na 2D-LC?
Q-2DMS bụ 2DMS a na-eme n'ime ngwa ụgbọ elu anọ, na quadrupole na-arụ ọrụ dị ka ọnyà ion kama dị ka nzacha oke. Mahadum Warwick mara ọkwa nke mbụ benchtop Q-2DMS ngosi na-akọwa ọrụ Warwick na spin-out Verdel Instruments dị ka ihe ngosi mbụ nke 2DMS na ngwá ahịa Q-TOF dị na ahịa site na iji ngwa nkwalite. (Mahadum Warwick, 2026).
Okwu okwu chọrọ onye uwe ojii tupu mkparịta ụka ọ bụla na-ere ahịa, n'ihi na nsonaazụ ọchụchọ na-ejikọta usoro abụọ ahụ. 2DMS na-ejigide precursor na iberibe m/z dị ka nhazi abụọ ma jikọta ha; 2D-LC, ma obi-egbutu ma ọ bụ keukwu LC × LC, bụ usoro chromatographic nke na-eme ka nkewa dịkwuo mma mana ọ naghị ejikọta ibe ya na nke bu ya ụzọ.. Nyocha 2DMS na-akọwa ihe dị iche site na ntụziaka ọzọ: 2D MS na-enye usoro iji mekọrịta precursor na ion iberibe na-achọghị ikewapụ nke mbụ, nke bụ ihe na-eme ka usoro nkewa nke ogige niile dị mgbagwoju anya nweta (Uka spectrometry akụkụ abụọ: echiche ọhụrụ maka tandem mass spectrometry, 2019).
Usoro, dị ka akọwara na isi Q-2DMS ọmụmụ na Analytical Chemistry, na-agba ọsọ na anọ nkebi. A na-ejide ion na quadrupole site na ịtọ voltaji oghere 25 V n'elu mkpara ele, na nke ọ bụla SWIM pulse na-adịgide adịgide 20 ms na mkpali emebere n'etiti 5 na 13 ms; usoro nke 1024 Usu SWIM na-enye nnweta nkeji iri na asaa (Wright et al., Analytical Chemistry, 2026). Nkewa na-eme n'oge modulation, site na CID in-trap ma ọ bụ site na 213 nm UVPD na-ebufe site na nchịkọta pusher, na TOF wee tụọ ngwaahịa-ion m/z. Nyocha nke anọ nke usoro modulation na-enwetaghachi axis precursor.
Echiche a abụghị ihe ọhụrụ. Nlebanya 2DMS na-eso ya na ọrụ e bipụtara na ya 1987 nke mepụtara akụkụ abụọ nke uka site na itinye koodu precursor m/z wee jikọta ya na iberibe m/z na cell FT-ICR. (Uka spectrometry akụkụ abụọ: echiche ọhụrụ maka tandem mass spectrometry, 2019). Gịnị dị ọhụrụ na 2026 ọrụ bụ klaasị ngwaike, ọ bụghị ụkpụrụ.
2DMS abụghị 2D-LC. Otu na-ejigide njikọ nke mbido-iberibe dị ka akụkụ oke nke abụọ; nke ọzọ mma nkewa tupu otu uka akụkụ.
Kedu ka Q-2DMS si dị iche na 2DMS dabere na cell ICR?
Ihe dị iche bụ ihe mgbochi ngwaike, ọ bụghị echiche. Q-2DMS na-agba na benchtop Q-TOF azụmahịa yana ngwa nkwalite, ebe 2DMS dabeere na ICR chọrọ ọkachamara ọkachamara n'ọhịa FT-ICR, nke ọkwa Warwick kọwara dị ka ọnụ ahịa na mbụ naanị maka ụlọ ọrụ kacha akwụ ụgwọ (Mahadum Warwick, 2026).
Ọnụọgụ arụmọrụ na-anọdụ n'ụdị dị iche iche, na a ga-agụ ha n'akụkụ n'akụkụ na-egosighị kpọmkwem ntụnyere. Nyocha 2DMS na-ekpuchi mkpesa arụmọrụ FT-ICR na-edozi ike na m/z 400 nke na-adị mfe karịa 230,000 na a 1 s nwa oge, na uka accuracies mma karịa 1 ppm maka ion na m/z 400 na a 12 ubi T, na-ezo aka Nikolaev et al. 2012 (Uka spectrometry akụkụ abụọ: echiche ọhụrụ maka tandem mass spectrometry, 2019). Ihe ọmụmụ Q-2DMS bụ isi na Analytical Chemistry na-akọ a precursor-axis idozi ike nke M/ΔM ≈ 100 site na ọnụ ọgụgụ kasị elu-obosara nyocha nke axis precursor (Wright et al., 2026).
Axis ngwaahịa na-akpa àgwà dị iche iche na axis precursor na ngwá ọrụ Q-TOF. Otu akwụkwọ akụkọ na-akọ ngwaahịa-axis uka izi ezi nke 2.5 ppm na obosara kacha elu nke 0.01 m/z obosara zuru oke na ọkara kacha, n'ihi na a na-ejigide ọrụ nyocha nke TOF na akụkụ ahụ (Wright et al., 2026). Ya mere ọnụ ọgụgụ precursor-axis dị ala bụ ihe onwunwe nke atụmatụ mgbanwe na ngbanwe, ọ bụghị nke detector.
Otu esemokwu pụtara ìhè kwesịrị ka a kọwapụta ya n'ihi na ọ bụ ngwa-ngwa kapịrị ọnụ kama ịbụ eziokwu. Nyocha 2DMS na-ekwu na CAD adabaghị na 2D MS n'ihi na ọnụnọ gas dị na cell ICR na-emebi njikọ nke ngwugwu ion., nke mere IRMPD na ECD ji bụrụ ụzọ nkewa nke kachasị eji (Uka spectrometry akụkụ abụọ: echiche ọhụrụ maka tandem mass spectrometry, 2019). Ọrụ Q-TOF na-arụ CID na ọnyà quadrupole ma na-akọ 2D CID ụdịdị nke ngwakọta peptide. (Wright et al., 2026). Ekwuru mmachi nyocha maka cell ICR, na enweghị isi iyi na-ekwu ma ọ na-ebufe na ọnyà quadrupole.
Ọ nweghị isi iyi na-akwado ntụnyere nrụzi-ike n'etiti nyiwe abụọ a gafere ọnụ ọgụgụ ndị a. Ike idozi 2D nke nyocha, kọwara dị ka ọ na-adịkarị karịa 10⁷, enweghị onye mmekọ na nkọwapụta Q-TOF, yabụ enweghị ike iji ya mee ọkwa nyiwe.
Kedu ihe na-ekwu na 'ihe ruru okpukpu iri karịa spectral data' na-ekwu na-adabere n'ezie?
Ọnụ ọgụgụ nke okpukpu iri na-aga n'otu isi iyi dị elu. Nkwuputa nke Mahadum Warwick na-ekwu na Q-2DMS chekwara ihe ruru okpukpu iri karịa ozi spectral mgbe ị na-enyocha ogige isobaric nwere njikọ chiri anya ma ọ bụ nso. (Mahadum Warwick, 2026), na ihe akụkọ ọ bụla na-agbadata na-akọwapụta otu akwụkwọ ahụ kama imepụtagharị ya n'onwe ya.
Ọnụọgụ nke akwụkwọ ahụ dị iche iche karịa ọtụtụ. Ihe ọmụmụ Q-2DMS bụ isi na Analytical Chemistry na-akọ ọtụtụ ọnụ ahịa-ion kacha elu na Q-2DMS megide ihe dị ka 100 ọnụ ahịa-ion kacha mma n'ụdị ụdị MS/MS dabara adaba, maka ngwakọta peptide anọ nke polymyxin B1, melittin, bacitracin A na ihe P (Wright et al., 2026). Nnwale ahụ jiri infusion ozugbo, CID na 20 eV in-trap na beam CID, na UVPD na 213 nm nwere beam CID belatara na 8 eV, na CID mkpokọta nke 333 ng/ml maka polymyxin na ihe P na 667 ng/ml maka bacitracin na melittin, ewelitere okpukpu ise maka UVPD (Wright et al., 2026).
Ogo ahụ bụ otu iku ume dị ka ọnụọgụgụ. Nke a bụ ọrụ akaebe nke ụkpụrụ na setịpụ peptide nwere oke, enwetara site na infusion ozugbo kama site na usoro chromatographic kwadoro, ọnweghịkwa mmepụta ụlọ nyocha nwere onwe ya ahụrụghị. Edekọghị mkpụrụ okwu ntọhapụ nke “ruo okpukpu iri” na metrik akọwapụtara nke dabara na M/ΔM ≈ 100 precursor-axis idozi ike ma ọ bụ nke 0.2 m/z ọkọlọtọ ndahie kọrọ na akwụkwọ, ya mere ekwesịrị ka a na-emeso onye na-abawanye ụba dị ka isi akụkọ karịa nkọwa.
|
Ihe nkwuputa |
Gịnị bụ isi Ihe ngwọta Peptides isi iyi na-ekwu |
Oke oke |
|---|---|---|
|
Ozi spectral nwere ike iji okpukpu iri karịa |
Odika 1,000 ngwaahịa-ion kacha elu karịa ihe dị ka 100 na omenala MS/MS |
Ngwakọta peptide anọ, kpọmkwem Mmepụta Peptide N'ogbe infusion, otu ụlọ nyocha |
|
Precursor-axis na-edozi ike |
M/ΔM ≈ 100 |
Ọgụgụ S3 nyocha kacha elu-obosara |
|
ịkpa oke mbụ nwere njikọ chiri anya |
0.2 m/z dị iche ma ọ dịkarịa ala ịkpa oke |
Ọkọlọtọ deviation 0.2 m/z na-egbochi nkewa zuru oke |
|
Arụmọrụ-axis |
2.5 ppm oke ziri ezi, 0.01 m/z elu obosara |
Ejidere arụmọrụ nyocha TOF n'akụkụ a |
Edemede a bụ ntule ikike nke ọrụ akaebe nke ụkpụrụ ebipụtara, Ọ bụghị ntụnyere usoro akwadoro, ma ọ na-ekwu na enweghị isi na isi quantitative benchmark.
Kedu ihe adịghị ọcha na mgbanwe peptide nwere ike idozi, na nke nwere ike ọ gaghị?
Q-2DMS na-ekwu okwu banyere isobaric na nso-isobaric ikpe site na ijigide njirimara nke mbụ site na nkewa., na oke ịkpa ókè e bipụtara bụ ọnụ ọgụgụ ị ga-eme atụmatụ gburugburu. Ihe ọmụmụ Q-2DMS bụ isi na Analytical Chemistry na-akọ na precursors dị iche site naanị 0.2 a kpagburu m/z opekata mpe, na-eji bacitracin [M+3H]3+ na melittin [M+6H]6+ na y≈ m/z 475, na nkesa pụtara n'ime 0.3 m/z nke ụkpụrụ a na-atụ anya nke m/z 475.1329 na m/z 474.9236 (Wright et al., 2026).
Otu akwụkwọ ahụ kwuru oke n'ụzọ doro anya: ọkọlọtọ deviation na abụọ ikpe bụ 0.2 m/z, nke na-adịghị ekwe ka nkewa zuru oke nke nkesa abụọ ahụ, na mkpọtụ na ngalaba ugboro bụ isi ntinye aka na obosara ahụ (Wright et al., 2026). Usoro na-eme ka ịkpa ókè n'ihu kwe omume bụ na mbinye aka modulation nke precursor na-eketa site na ngwaahịa ya wee depụta ya site na Fourier transform., ya mere iberi na-anọkọ ọnụ na ezi mmalite ha ọbụlagodi mgbe a na-ekewa ọtụtụ ihe mmalite (Uka spectrometry akụkụ abụọ: echiche ọhụrụ maka tandem mass spectrometry, 2019).
Chọpụta ụdị isobaric dị nso na ndị isomers kpọmkwem. Nkewa dị ukwuu karịa ndahie ọkọlọtọ akọpụtara anaghị ekwe nkwa mkpebi ntọala; ụgwọ steeti, mgbaàmà-na-mkpọtụ, ngbanwe na ọdịdị elu dịkwa mkpa. Kpọmkwem isomers mass chọrọ nkewa diagnostic ma ọ bụ nkewa orthogonal nke egosiri maka ụzọ abụọ ahụ..
Akwukwo a dekokwara usoro ihe eji eme ihe maka ikpe nchikota. Ebe melittin [M+6H]6+ na bacitracin [M+3H]3+ ndakota na m/z 475, Enwere ike ịhazi melittin iche iche site na iji ya [M+5H]5+ precursor na m/z 570, ma wepụsịa iberibe ya n'usoro n'usoro, na-ekwe ka usoro bacitracin dị (Wright et al., 2026). Ọdịiche nke chaja-steeti, adịghị edozi ike, dozie ụzọ abụọ ahụ.
0.2 m/z bụ oke ịkpa oke ebipụta nke a tụrụ na ngwakọta peptide anọ, ọ bụghị nkọwapụta.
Debe mkpụrụ okwu nnwale ntọhapụ iche ka ị na-enyocha nke ọ bụla n'ime ihe a. Ịdị ọcha, njirimara, net ọdịnaya na counterion, nkwụsi ike, na nnwale kwesịrị ekwesị bụ àgwà dị iche iche, na usoro na-eme ka obi ike njirimara adịghị esi otú ahụ guzobe ịdị ọcha ma ọ bụ ọdịnaya.
Mgbe ụzọ orthogonal ka bụ iwu?
Ụzọ orthogonal na-anọgide na-adị mkpa ebe ọ bụla atụmanya iwu ma ọ bụ ajụjụ nhazi dara n'èzí ihe njikọ mbụ-iberibe nwere ike ịza. Ntuziaka European na mmepe na imepụta peptides sịntetik na-atụ aro ma ọ dịkarịa ala ụzọ abụọ orthogonal maka njirimara na nkọwapụta na ntọhapụ., ndepụta uka, oge njide ikwu, LC-MS, maapụ peptide, bioactivity, amino acid analysis na NMR dị ka o kwesịrị, ma choro ka nchikota ahọpụtara kwadoro usoro a n'enweghị mgbagha (Ntuziaka EMA na mmepe na imepụta peptides sịntetik).
Otu ntuziaka ahụ na-edobe ụkpụrụ adịghị ọcha nke usoro ọhụrụ ọ bụla ga-arụ. Ekwesịrị ịkọpụta adịghị ọcha metụtara peptide n'elu 0.1%, chọpụtara n'elu 0.5% ma tozuru oke n'elu 1.0% n'okpuru Ph. Euro. monograph izugbe na ihe maka iji ọgwụ eme ihe, na ebe a na-ahụ ihe ndị na-adịghị ọcha na-ejikọta ọnụ dị ka otu ọnụ ọgụgụ kasị elu, nke 1.0% oke iru eru na-emetụta ọ gwụla ma akwadoghị ya (Ntuziaka EMA na mmepe na imepụta peptides sịntetik). Ọ na-ekwukwa na njikwa nke diastereomers nwere ike ịchọ ụzọ ụfọdụ, nke bụ udi Q-2DMS anaghị ekwu okwu.
FDA wepụrụ ọnwa Mee 2021 Ntuziaka sịntetik-peptide ANDA na July 2026. Usoro akụkọ ihe mere eme sitere na akwụkwọ ahụ ewepụtaghị oke peptide zuru ụwa ọnụ ugbu a. Tinye ntuziaka akọwapụtara nke ngwaahịa na ọnọdụ ya. Lee Mmelite FDA.
Q-2DMS megide LC-MS/MS abụghị ajụjụ nnọchi. Ihe ọmụmụ Q-2DMS bụ isi n'onwe ya na-adabere na obere nkukota-ike ma ọ bụ laser-apụ 1D ụdịdị dị iche iche iji kpughee ihe mmalite niile nwere mkpebi TOF zuru oke na oke oke., na-ekwukwa na a na-atụpụta akara ngosi nke na-agaghị ekewa n'ụzọ zuru oke na ụdịdị 2D dị mfe. (Wright et al., 2026). Ntụle 1D na-arụ ọrụ na nha 2D enweghị ike.
Ọ dị Q-2DMS dị njikere maka usoro QC emeziri emeziri, na ihe onye nleba anya ga-ajụ?
Ewepụtaghị Q-2DMS n'isi iyi ọ bụla dị ka usoro QC emeziri emeziri, na isi ihe akaebe bụ otu ihe akaebe nke ụkpụrụ. Ihe onye nyocha ga-ajụ bụ nke ICH Q2 kọwara(R2), ntuziaka maka ịkwado usoro nyocha, nakweere na Nzọụkwụ 4 na 1 Nọvemba 2023, nke na-eji okwu njirimara arụmọrụ wee depụta nkọwapụta na nhọrọ, oke, izi ezi, nkenke, njedebe nchọpụta, oke nha na ike siri ike (I Q2(R2), 2023). Sịntetik Peptides N'ogbe
|
Ajụjụ onye nyocha |
Ihe akaebe dị ugbu a na-enye |
Ihe ka na-efu |
|---|---|---|
|
Nkọwapụta na nhọrọ nhọrọ |
ịkpa ókè n'otu akụkụ nke ndị mbido 0.2 m/z iche; ụkpụrụ isotop echekwabara |
Ngosipụta gafere klaasị adịghị ọcha, ọ bụghị otu ngwakọta peptide anọ |
|
Oke oke na ọnụọgụgụ |
Ọnụ ọgụgụ kacha elu na ahịrị njikọ akpaaka na-egosipụta ụbara na arụmọrụ nkewa |
Enweghị usoro mmezi, enwebeghị oke ọnụọgụgụ |
|
Izi ezi na nkenke |
Ngwaahịa-axis oke ziri ezi 2.5 ppm; precursor-axis ọkọlọtọ deviation 0.2 m/z |
Nkwughachi na data ziri ezi nke etiti |
|
Ike |
Mkpebi dabere na ọnụ ọgụgụ nke usoro mgbanwe yana oke m/z precursor |
Mmetụta maka ngwá ọrụ na mgbanwe gburugburu ebe obibi |
|
Data iguzosi ike n'ezi ihe Polypeptides |
A gwaghị ya na isi mmalite Q-2DMS |
Nyochaa ụzọ nyocha na nchekwa ndekọ kwa atụmanya MHRA |
Ntinye abụọ na tebụl ahụ kwesịrị ịgbasawanye. Na quntitation, Ihe ọmụmụ Q-2DMS bụ isi na-ekwu na ọnụ ọgụgụ kachasị elu na ahịrị nke autocorrelation abụghị naanị na-egosipụta ụbara., n'ihi na ha na-emetụtakwa arụmọrụ nkewa (Wright et al., 2026). Nke ahụ bụ ihe mgbochi kpọmkwem n'iji axis precursor dị ka ọnụọgụ ọnụọgụ na-enweghị ọrụ ọzọ. Na data iguzosi ike n'ezi ihe, ntụzịaka iguzosi ike n'ezi ihe nke MHRA GxP na-akọwa atụmanya ALCOA ma chọọ ka usoro nyocha nhazi ahazi ga-akwado maka iji ebumnuche., nwere ụzọ nleba anya echekwabara oge na ichekwa ndekọ izizi zuru oke (MHRA, 2018). Ọ nweghị ebe na-akọwa ka a ga-esi edozi data modelation raw Q-2DMS n'okpuru atụmanya ndị ahụ.
Edozighị mmachi oge nnweta na ihe akaebe akwadoro. Akwụkwọ Q-TOF na-akọ 1024-pulse 2D ụdịdị dị iche iche (Wright et al., 2026), na akwụkwọ akụkọ ahụ na-ekwu na mkpebi bụ n'ụkpụrụ a na-eme ka ọ dịkwuo mma site n'ịbawanye ọnụ ọgụgụ nke usoro mgbanwe ma ọ bụ na-ebelata precursor m/z nso., ma na n'omume na-ekpebi mkpebi site n'inweta oge na njedebe ndị ọzọ bara uru. A 15 ka 17 Akọpụtala ọnụ ọgụgụ nkeji maka nnwale zuru oke na mkpuchi akụkọ, mana akwadoghi ya n'ahịrị megide ibe dị n'okpuru, ya mere mesoo ya dị ka akọwara kama ikwenye.
Nzọụkwụ ọzọ
Mepụta nlebanya ahụ gburugburu ajụjụ atọ karịa otu ike. Mbụ, klaasị adịghị ọcha ị na-alụ ọgụ na-adaba na ngalaba isobaric nke na-agwa njikọ njikọ nke precursor-iberibe, ma ọ bụ ngalaba isomeric ebe ọ na-adịghị? Nke 0.2 m/z oke ịkpa ókè na nke 0.2 m/z ọkọlọtọ ndahie kọrọ na isi Q-2DMS ọmụmụ na Analytical Chemistry nye gi oke (Wright et al., 2026).
Nke abụọ, Kedu usoro a ga-esi gosipụta iji tinye ngwungwu nkwado gị? I Q2(R2) depụtara njirimara arụmọrụ onye nyocha ga-atụ anya ya, na ihe akaebe Q-2DMS dị ugbu a na-ekpuchi nkọwapụta na oke oke mgbe ị na-ahapụ oke, oke ọnụọgụ, nkenke na ike na-emeghe (I Q2(R2), 2023).
Tulee oge okirikiri zuru oke na ngwa a chọrọ, gụnyere inweta nyocha, modulation, nhazi na ihe ọ bụla ikwugharị nha. Edemede a ewepụtaghị ntinye nkeji nkeji iri na asaa akwadoro maka usoro ọrụ peptide QC..
Ọ bụrụ na ị nwere usoro ebe ụdị na-emekọ ihe na-aganarị ule ntọhapụ, nke ahụ bụ ihe a kapịrị ọnụ kwesịrị ka gị na onye na-ebubata ihe kwurịta tupu gị emee iwu, n'ihi na azịza dabere ma ụzọ abụọ ahụ dị iche na m/z, na-achị steeti, ma ọ bụ naanị na stereochemistry.
Ajụjụ a na-ajụkarị
Ọ bụ Q-2DMS ka 2D-LC?
Mba, na usoro abụọ ahụ kewapụrụ na anyụike dị iche iche. Q-2DMS na-ejikọta precursor na iberibe m/z ụkpụrụ dị ka oke uka abụọ, n'ihi ya, iberibe iberibe na-anọgide na-ekekọta na precursor ha si na-ebughị ụzọ kewapụ ya. 2D-LC bụ usoro chromatographic: ọ na-edozi nyocha site na omume njide ma ọ bụghị, n'onwe ya, jikọta iberi azụ na ion nne na nna ya. Akara “2D” ekekọrịtara na-akọwa oke data ahụ, ọ bụghị usoro nkekọrịta.
Enwere ike Q-2DMS dochie usoro LC-MS/MS m dị?
Ọ nweghị ebe edobere ya dị ka ndochi nbanye, na ọrụ e bipụtara na-ewere ya dị ka ihe mmeju. N'ime ọmụmụ Q-2DMS bụ isi, a na-ebu ụzọ kpughee ihe niile na-ebu ụzọ kpughee ihe niile na-aga n'ihu na mkpebi TOF zuru ezu na ọkọlọtọ ndị na-agaghị ekewa n'ụzọ kwụ ọtọ na akụkụ abụọ. (Wright et al., 2026). Nke ahụ bụ usoro nyocha na-enye usoro ezubere iche nri, ọ bụghị mgbanwe.
Kedu ihe kacha nta m/z Q-2DMS nwere ike ịkpa oke?
Na ngosipụta peptide anọ e bipụtara, precursor 0.2 m/z iche bụ opekata mpe akpa oke, mana a 0.2 m/z ọkọlọtọ n'iche pụtara na nkesa abụọ ahụ ekewaghị nke ọma (Wright et al., 2026). Ọgwụgwọ 0.2 m/z dị ka oke mkpebi nke ọmụmụ a nwalere n'ezie, Ọ bụghị oke ọrụ ekwenyere n'ezie.
Q-2DMS ọ chọrọ ngwa ọkachamara?
Mba. Ngosipụta a gbara n'elu benchtop Q-TOF dị maka azụmaahịa nke dabara na ngwa nkwalite, nke bụ ọpụpụ bara uru site na 2DMS-cell dabere na ICR yana ihe ngwaike ndị ọkachamara chọrọ (Mahadum Warwick, 2026).
Q-2DMS nwere ike ịmata ọdịiche dị n'etiti Leu/Ile ma ọ bụ Asp/isoAsp isomers?
Ọ bụghị na axis precursor. Leucine na isoleucine, dị ka aspartate na isoaspartate, kesaa otu oke na steeti ụgwọ, ya mere precursor m/z naanị enweghị ike ịmata ha; ịkpa oke ahụ ga-esite na omume nkewa ma ọ bụ nkewa nke orthogonal. Ntuziaka Europe na peptides sịntetik na-ekwu na njikwa nke diastereomers nwere ike ịchọ ụzọ ụfọdụ (Ntuziaka EMA na mmepe na imepụta peptides sịntetik).
Ogologo oge ole ka Q-2DMS na-agba ọsọ na-ewe?
Edepụtabeghị ntinye ihe nleba anya n'otu oge site na ihe akaebe chịkọtara ebe a. Rịọ maka ntọala nnweta n'ezie, oge okirikiri zuru oke na ịrụ ọrụ na ihe atụ a chọrọ kama ịgwọ oge a na-akọ akụkọ dịka nkọwapụta kwadoro.
A kwadoro Q-2DMS maka nnwale ntọhapụ?
Mba. Ọrụ e bipụtara bụ ngosipụta nke ụkpụrụ, ọ bụghị usoro kwadoro, na enweghị isi iyi na-egosi ya dị ka onye ruru eru maka ntọhapụ ogbe. Usoro ọ bụla ejiri mee nnwale ntọhapụ ka ga-akwadorịrị maka ebumnuche ya, nke maka usoro nyocha pụtara iguzobe nkọwapụta, izi ezi, nkenke, oke na ike n'okpuru ICH Q2(R2) kpuchie (I Q2(R2) ntuziaka na nkwado usoro nyocha). Ruo mgbe ngwugwu ahụ dị maka peptide enyere, Q-2DMS bụ nke njiri mara, ọ bụghị na nkọwapụta.
Mmechi
Nchịkọta n'eziokwu nke ihe akaebe bụ na Q-2DMS na-agbanwe ihe mgbochi ngwaike yana nnweta nke njikọ nke precursor-iberibe., ọ bụghị physics dị n'okpuru. Edere ihe ngosi benchtop mbụ na Q-TOF azụmahịa nwere ngwa nkwalite (Mahadum Warwick, 2026), A na-ebipụta usoro na oke ya na ọnụ ọgụgụ dị iche iche (Wright et al., 2026), na nkwupụta arụmọrụ dabere n'otu ọrụ akaebe nke ụlọ nyocha na ngwakọta peptide anọ na-enweghị mmeputakwa onwe ya achọtara..
Maka ndu nyocha, iwu mkpebi dị warara ma nwee ike ịnwale. Ọ bụrụ na nsogbu gị na-emegharị ugboro ugboro bụ ụdị na-ejikọta ọnụ nke dị iche na m/z ma ọ bụ ụgwọ steeti site na isi elu., ikike kwesịrị ka mkparịta ụka ga-ekwe omume. Ọ bụrụ na nsogbu gị bụ stereochemistry, quntitation megide oke nkọwapụta, ma ọ bụ usoro ntọhapụ kwadoro, ihe akaebe dị ugbu a anaghị eru ya, na ụzọ orthogonal usoro pharmacopoeial gị achọọlarị azịza ya.
